Humedix Co., Ltd. (KOSDAQ:200670)
40,350
-750 (-1.82%)
Dec 30, 2025, 3:30 PM KST
Humedix Market Cap
Humedix has a market cap or net worth of 424.16 billion as of December 30, 2025. Its market cap has increased by 27.78% in one year.
Market Cap
424.16B
Enterprise Value
n/a
Revenue
110.99B
Ranking
n/a
PE Ratio
42.64
Stock Price
40,350.00
Market Cap Chart
Since December 26, 2014, Humedix's market cap has increased from 223.01B to 424.16B, an increase of 90.20%. That is a compound annual growth rate of 6.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2025 | 416.42B | -4.39% |
| Dec 30, 2024 | 435.54B | 24.67% |
| Dec 28, 2023 | 349.36B | 38.28% |
| Dec 29, 2022 | 252.65B | 12.18% |
| Dec 30, 2021 | 225.21B | -0.11% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 78.32T |
| Celltrion | 39.67T |
| ALTEOGEN | 24.33T |
| ABL Bio | 10.99T |
| SK Biopharmaceuticals | 9.83T |
| Yuhan | 8.44T |
| LigaChem Biosciences | 6.55T |
| HLB Co., Ltd. | 6.45T |